Furukawa Kenichiro, Hatakeyama Keiichi, Terashima Masanori, Fujiya Keiichi, Tanizawa Yutaka, Bando Etsuro, Sugino Takashi, Urakami Kenichi, Naito Tateaki, Kagawa Hiroyasu, Yamaguchi Ken
Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.
Medical Genetics Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.
Surg Case Rep. 2022 Dec 2;8(1):214. doi: 10.1186/s40792-022-01566-8.
When a patient has multiple tumors in different organs, it is very important to identify whether the tumors are multiple cancers or metastasis from one tumor in order to establish an optimal treatment strategy. However, it is difficult to obtain an accurate diagnosis from conventional diagnostic strategies, including immunohistochemistry. We report two patients with multiple tumors in which a somatic mutation comparison using next-generation sequencing (NGS) was useful for the diagnosis of a metastatic tumor.
Patient 1: A 64-year-old man was diagnosed with gastric and lung cancer. After radical chemoradiotherapy for lung cancer, gastrectomy was planned for gastric cancer. At gastrectomy, the patient underwent a multiple omics analysis for "Project HOPE". The gene mutational signature of the gastric tumor showed signature 4 of COSMIC mutational signature version 2, which was associated with smoking and has not been found in gastric cancer. To confirm that the gastric tumor was metastasis from lung cancer, we conducted a somatic mutation comparison of the two tumors with 409-gene panel sequencing, which revealed that 28 of 97 mutations in the lung tumor completely matched those of the gastric tumor. Based on these findings, the gastric tumor was diagnosed as metastasis from lung cancer. Patient 2: A 47-year-old woman underwent distal gastrectomy for gastric cancer. A colon tumor was detected 6 years after gastrectomy. The colon lesion was a submucosal tumor-like elevated tumor, and was suspected to be metastasis from gastric cancer. The patient underwent sigmoidectomy, and participated in "Project HOPE". The possibility of primary colon cancer could not be ruled out, and we conducted a somatic mutation comparison of the two tumors as we did with Patient 1. Panel sequencing revealed 11 mutations in the gastric tumors, 4 of which completely matched those of the colon tumor. The colon tumor was diagnosed as metastasis from gastric cancer.
We reported two patients with multiple tumors in which a somatic mutation comparison using NGS was useful for the diagnosis of a metastatic tumor.
当患者在不同器官出现多个肿瘤时,确定这些肿瘤是多发性癌症还是源自一个肿瘤的转移瘤对于制定最佳治疗策略非常重要。然而,包括免疫组化在内的传统诊断策略难以获得准确诊断。我们报告了两名患有多个肿瘤的患者,其中使用二代测序(NGS)进行体细胞突变比较有助于转移性肿瘤的诊断。
患者1:一名64岁男性被诊断为胃癌和肺癌。在对肺癌进行根治性放化疗后,计划对胃癌进行胃切除术。在胃切除术中,患者参与了“希望计划”的多项组学分析。胃肿瘤的基因突变特征显示为COSMIC突变特征版本2的特征4,这与吸烟有关,在胃癌中尚未发现。为了确认胃肿瘤是肺癌转移所致,我们对两个肿瘤进行了409基因panel测序的体细胞突变比较,结果显示肺肿瘤的97个突变中有28个与胃肿瘤的突变完全匹配。基于这些发现,胃肿瘤被诊断为肺癌转移。患者2:一名47岁女性因胃癌接受了远端胃切除术。胃切除术后6年发现结肠肿瘤。结肠病变是一个黏膜下肿瘤样隆起性肿瘤,怀疑是胃癌转移。患者接受了乙状结肠切除术,并参与了“希望计划”。不能排除原发性结肠癌的可能性,我们像对患者1那样对两个肿瘤进行了体细胞突变比较。panel测序显示胃肿瘤中有11个突变,其中4个与结肠肿瘤的突变完全匹配。结肠肿瘤被诊断为胃癌转移。
我们报告了两名患有多个肿瘤的患者,其中使用NGS进行体细胞突变比较有助于转移性肿瘤的诊断。